D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 501–600 of 1,013
Joyce, J. N. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90016-6 · Cited by 126
Shirayama, Y., Mitsushio, H., Takashima, M., Ichikawa, H., & Takahashi, K. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00812-8 · Cited by 126
Separate, Causal Roles of the Caudate in Saccadic Choice and Execution in a Perceptual Decision Task
Ding, L., & Gold, J. I. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.021 · Cited by 125
Ouchi, Y. (2001) · Brain · doi:10.1093/brain/124.4.784 · Cited by 125
Zhang, X., Andren, P. E., Greengard, P., & Svenningsson, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711839105 · Cited by 117
Bolam, J. P., & Smith, Y. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903210312 · Cited by 125
Merchant, K., Dobner, P., & Dorsa, D. M. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00652.1992 · Cited by 125
Members, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124
Diaz, J., Ridray, S., Mignon, V., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04282.1997 · Cited by 124
Mailleux, P., & Vanderhaeghen, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09807.x · Cited by 124
Golden, S. A., Jin, M., Heins, C., Vènniro, M., Michaelides, M., & Shaham, Y. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2409-18.2019 · Cited by 124
Sun, X., Milovanovic, M., Zhao, Y., & Wolf, M. E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0258-08.2008 · Cited by 112
Mottola, D. M., Kilts, J. D., Lewis, M. M., Connery, H. S., Walker, Q. D., Jones, S. R., Booth, R. G., Hyslop, D. K., Piercey, M., Wightman, R. M., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1166 · Cited by 123
A Review of the Properties of Spiradoline: A Potent and Selective k‐Opioid Receptor Agonist
Wadenberg, M. G. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00248.x · Cited by 123
Le Moine, C., Svenningsson, P., Fredholm, B. B., & Bloch, B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-08038.1997 · Cited by 123
Pourcher, E., Fernandez, H. H., Stacy, M. A., Mori, A., Ballerini, R., & Chaikin, P. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.09.023 · Cited by 123
Cenci, M. A., Campbell, K., Wictorin, K., & Björklund, A. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00885.x · Cited by 119
Dopamine Invigorates Reward Seeking by Promoting Cue-Evoked Excitation in the Nucleus Accumbens
du Hoffmann, J., & Nicola, S. M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3492-14.2014 · Cited by 122
“Alternatively (or in addition), the interaction between D1 and D2 (and/or D3) receptors may occur at the local circuit level (Goto and Grace, 2005; Gerfen and Surmeier, 2011).”
BackgroundGangarossa, G., Espallergues, J., de Kerchove d'Exaerde, A., El Mestikawy, S., Gerfen, C. R., Hervé, D., Girault, J.-A., & Valjent, E. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00022 · Cited by 122
Self-citationA Kinetic Model of Dopamine- and Calcium-Dependent Striatal Synaptic Plasticity
Nakano, T., Doi, T., Yoshimoto, J., & Doya, K. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000670 · Cited by 122
Basal Ganglia Dysfunction Contributes to Physical Inactivity in Obesity
Friend, D. M., Devarakonda, K., O’Neal, T. J., Skirzewski, M., Papazoglou, I., Kaplan, A. R., Liow, J.-S., Guo, J., Rane, S. G., Rubinstein, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.001 · Cited by 121
Deffains, M., Iskhakova, L., Katabi, S., Haber, S. N., Israel, Z. H., & Bergman, H. (2016) · eLife · doi:10.7554/elife.16443 · Cited by 121
A distinct D1-MSN subpopulation down-regulates dopamine to promote negative emotional state
Liu, Z., Le, Q., Lv, Y., Chen, X., Cui, J., Zhou, Y., Cheng, D., Ma, C., Su, X., Xiao, L., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00588-5 · Cited by 121
Synaptic plasticity in the basal ganglia
Wickens, J. R. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.030 · Cited by 121
Nakanishi, S., Hikida, T., & Yawata, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.026 · Cited by 121
New insights into dopamine receptors in the central nervous system
Strange, P. G. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90050-f · Cited by 121
Gangarossa, G., Espallergues, J., Mailly, P., De Bundel, D., de Kerchove d'Exaerde, A., Hervé, D., Girault, J.-A., Valjent, E., & Krieger, P. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00124 · Cited by 120
Methylphenidate-induced dendritic spine formation and ΔFosB expression in nucleus accumbens
Kim, Y., Teylan, M. A., Baron, M., Sands, A., Nairn, A. C., & Greengard, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813179106 · Cited by 120
Bontempi, B., & Sharp, F. R. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08596.1997 · Cited by 120
Neurocomputational models of motor and cognitive deficits in Parkinson’s disease
Wiecki, T. V., & Frank, M. J. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83014-6 · Cited by 120
Adaptive properties of differential learning rates for positive and negative outcomes
Cazé, R. D., & van der Meer, M. A. A. (2013) · Biological Cybernetics · doi:10.1007/s00422-013-0571-5 · Cited by 120
Yuan, X.-S., Wang, L., Dong, H., Qu, W., Yang, S.-R., Chérasse, Y., Lazarus, M., Schiffmann, S. N., d’Exaerde, A. D. K., Li, R., et al. (2017) · eLife · doi:10.7554/elife.29055 · Cited by 120
Schmidt, H. D., Anderson, S. M., & Pierce, R. C. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04524.x · Cited by 119
“It should be emphasized, however, that in the nucleus accumbens D1 receptors are expressedmainly on neurons that project to the VTA, whereas D2 receptors are preferentially found on neurons that project to the ventral pallidum (Gerfen et al., 1990; Bloch & Le Moine, 1994; Lu et al., 1998).”
BackgroundVentral Pallidum Is the Primary Target for Accumbens D1 Projections Driving Cocaine Seeking
Pardo-Garcia, T. R., Garcia-Keller, C., Penaloza, T., Richie, C. T., Pickel, J., Hope, B. T., Harvey, B. K., Kalivas, P. W., & Heinsbroek, J. A. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2822-18.2018 · Cited by 119
Striatal direct and indirect pathways control decision-making behavior
Macpherson, T., Morita, M., & Hikida, T. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01301 · Cited by 96
Romero, J., Berrendero, F., Pérez‐Rosado, A., Manzanares, J., Rojo, A., Fernández‐Ruíz, J., de Yébenes, J. G., & Ramos, J. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00618-9 · Cited by 119
Motor Dysfunction in Type 5 Adenylyl Cyclase-null Mice
Iwamoto, T., Okumura, S., Iwatsubo, K., Kawabe, J.-I., Ohtsu, K., Sakai, I., Hashimoto, Y., Izumitani, A., Sango, K., Ajiki, K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300075200 · Cited by 118
The functional logic of corticostriatal connections
Shipp, S. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1250-9 · Cited by 118
“marries their connectional status to a neurochemical signature: dSPNs express D1 dopamine receptors and their GABAergic transmission is characterised by peptide cotransmitters substance P and dynorphin; iSPNs express D2 dopamine receptors and use met-enkephalin as a co-transmitter (Gerfen et al. 1990; Graybiel 1990).”
BackgroundInfluentialFauchey, V., Jaber, M., Caron, M. G., Bloch, B., & Le Moine, C. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00876.x · Cited by 118
SURGERY FOR MOVEMENT DISORDERS
Rezai, A. R., Machado, A. G., Deogaonkar, M., Azmi, H., Kubu, C., & Boulis, N. M. (2008) · Neurosurgery · doi:10.1227/01.neu.0000316285.52865.53 · Cited by 113
Vila, M., Lévy, R., Herrero, M. T., Faucheux, B. A., Obeso, J. A., Agid, Y., & Hirsch, É. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00549-8 · Cited by 118
Morissette, M., Goulet, M., Soghomonian, J., Blanchet, P. J., Calon, F., Bédard, P. J., & Paolo, T. D. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00123-x · Cited by 117
Lin, Y., Jan, Y. N., & Jan, L. Y. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.942 · Cited by 117
Stefanik, M. T., Kupchik, Y. M., Brown, R. M., & Kalivas, P. W. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1570-13.2013 · Cited by 116
Durante, V., de Iure, A., Loffredo, V., Vaikath, N., De Risi, M., Paciotti, S., Quiroga-Varela, A., Chiasserini, D., Mellone, M., Mazzocchetti, P., et al. (2019) · Brain · doi:10.1093/brain/awz065 · Cited by 116
Uslaner, J., Badiani, A., Norton, C. S., Day, H. E. W., Watson, S. J., Akil, H., & Robinson, T. E. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01574.x · Cited by 116
Moyer, J. T., Wolf, J. A., & Finkel, L. H. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00335.2007 · Cited by 116
Castle, M., Aymerich, M. S., Sanchez‐Escobar, C., Gonzalo, N., Obeso, J. A., & Lanciego, J. L. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20421 · Cited by 116
Uslaner, J. M., Badiani, A., Day, H. E. W., Watson, S. J., Akil, H., & Robinson, T. E. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03040-2 · Cited by 116
Yawata, S., Yamaguchi, T., Danjo, T., Hikida, T., & Nakanishi, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210797109 · Cited by 115
Treatment of severe axial tardive dystonia with clozapine: Case report and hypothesis
Trugman, J. M., Leadbetter, R. A., Zalis, M. E., Burgdorf, R. O., & Wooten, G. F. (1994) · Movement Disorders · doi:10.1002/mds.870090411 · Cited by 115
Thibault, D., Loustalot, F., Fortin, G. M., Bourque, M.-J., & Trudeau, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067219 · Cited by 114
Bagetta, V., Picconi, B., Marinucci, S., Sgobio, C., Pendolino, V., Ghiglieri, V., Fusco, F. R., Giampà, C., & Calabresi, P. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2236-11.2011 · Cited by 114
Pathophysiology of Parkinson's disease
Bonnet, A. M., & Houéto, J. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80076-6 · Cited by 114
Gruber, A. J., Solla, S. A., Surmeier, D. J., & Houk, J. C. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00618.2002 · Cited by 114
Basal ganglia — possible role in motor coordination and learning
HIKOSAKA, O. (1991) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(05)80042-x · Cited by 114
Gαo is a major determinant of cAMP signaling in the pathophysiology of movement disorders
Muntean, B. S., Masuho, I., Dao, M. T., Sutton, L. P., Zucca, S., Iwamoto, H., Patil, D. N., Wang, D., Birnbaumer, L., Blakely, R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108718 · Cited by 113
Cellular principles underlying normal and pathological activity in the subthalamic nucleus
Bevan, M. D., Atherton, J. F., & Baufreton, J. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.10.003 · Cited by 113
The basal ganglia: anatomy, physiology, and pharmacology
Tisch, S. H., Silberstein, P., Limousin, P. D., & Jahanshahi, M. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.06.004 · Cited by 113
Heterogeneous properties of central lateral and parafascicular thalamic synapses in the striatum
Ellender, T. J., Harwood, J., Kosillo, P., Capogna, M., & Bolam, J. P. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.245233 · Cited by 113
Zeng, B. ‐., Pearce, R. K. B., MacKenzie, G. M., & Jenner, P. G. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00988.x · Cited by 113
Oldenburg, I. A., & Sabatini, B. L. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.008 · Cited by 112
Brain Dopamine Receptors: A Primer on Their Current Status, Basic and Clinical
Baldessarini, R. J., & Tarazi, F. I. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017200 · Cited by 112
Mathieu-Kia, A.-M., & Besson, M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00338-0 · Cited by 112
Kim, S., Shou, J., Abera, S., & Ziff, E. B. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.041 · Cited by 112
The Neurochemistry of Human Aggression
Yanowitch, R. N., & Coccaro, E. F. (2011) · Advances in genetics · doi:10.1016/b978-0-12-380858-5.00005-8 · Cited by 111
Long-Term Changes in Basal Ganglia Function after a Neurotoxic Regimen of Methamphetamine
Chapman, D. E., Hanson, G. R., Kesner, R. P., & Keefe, K. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38769-5 · Cited by 111
Gerfen, C. R. (2003) · The Neuroscientist · doi:10.1177/1073858403255839 · Cited by 111
Self-citationCahill, E., Salery, M., Vanhoutte, P., & Caboche, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00172 · Cited by 111
Industry forum: Progress in pursuit of therapeutic A2Aantagonists
Kase, H., Aoyama, S., Ichimura, M., Ikeda, K., Ishii, A., Kanda, T., Koga, K., Koike, N., Kurokawa, M., Kuwana, Y., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000095219.22086.31 · Cited by 111
Self-citationTel, B. C., Zeng, B. ‐., Cannizzaro, C., Pearce, R. K. B., Rose, S., & Jenner, P. G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00535-3 · Cited by 111
Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease
Lee, W. Y., Yoon, W. T., Shin, H. Y., Jeon, S. H., & Rhee, P. (2008) · Movement Disorders · doi:10.1002/mds.22190 · Cited by 110
κ-Opioid Receptors within the Nucleus Accumbens Shell Mediate Pair Bond Maintenance
Resendez, S. L., Kuhnmuench, M., Krzywosinski, T., & Aragona, B. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5779-11.2012 · Cited by 110
“Moreover, activation of D1-like receptors increases dynorphin levels (Gerfen et al., 1990), indicating a direct interaction between these systems.”
BackgroundWardas, J., Konieczny, J., & Lorenc‐Koci, E. (2001) · Synapse · doi:10.1002/syn.1070 · Cited by 110
Drakenberg, K., Nikoshkov, A., Horváth, M. C., Fagergren, P., Gharibyan, A., Saarelainen, K., Rahman, S., Nylander, I., Bakalkin, G., Rajs, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600871103 · Cited by 109
Jaber, M., Cador, M., Dumartin, B., Normand, E., Stinus, L., & Bloch, B. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00537-f · Cited by 109
Jiang, H., Jackson-Lewis, V., Muthane, U., Dollison, A., Ferreira, M., Espinosa, A., Parsons, B., & Przedborski, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90925-d · Cited by 99
The pathophysiology of chorea/ballism and Parkinsonism
Albin, R. L. (1995) · Parkinsonism & Related Disorders · doi:10.1016/1353-8020(95)00011-t · Cited by 109
Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice
Adams, M. R., Brandon, E. P., Chartoff, E. H., Idzerda, R. L., Dorsa, D. M., & McKnight, G. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12157 · Cited by 109
Kronman, H., Torres-Berrío, A., Sidoli, S., Issler, O., Godino, A., Ramakrishnan, A., Mews, P., Lardner, C. K., Parise, E. M., Walker, D. M., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00814-8 · Cited by 108
Taymans, J., Leysen, J. E., & Langlois, X. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01610.x · Cited by 108
Cortical Stimulation Evokes Abnormal Responses in the Dopamine-Depleted Rat Basal Ganglia
Kita, H., & Kita, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0915-11.2011 · Cited by 108
Dopamine Receptor Signaling and Current and Future Antipsychotic Drugs
Boyd, K. N., & Mailman, R. B. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25761-2_3 · Cited by 107
Hervé, D. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00048 · Cited by 107
Ronesi, J. A., & Lovinger, D. M. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.068460 · Cited by 107
Morissette, M., Grondin, R., Goulet, M., Bédard, P. J., & Di Paolo, T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720682.x · Cited by 101
Implications of prolonged expression of Fos-related antigens
Pennypacker, K. R., Hong, J., & McMillian, M. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89061-6 · Cited by 107
André, V. M., Cepeda, C., Cummings, D. M., Jocoy, E. L., Fisher, Y. E., William Yang, X., & Levine, M. S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07047.x · Cited by 95
Calon, F., Goulet, M., Blanchet, P. J., Martel, J. C., Piercey, M. F., Bédard, P. J., & Paolo, T. D. (1995) · Brain Research · doi:10.1016/0006-8993(95)00229-j · Cited by 106
Morelli, M., Fenu, S., Pinna, A., & Chiara, G. D. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90438-3 · Cited by 106
K�ppenbender, K. D., Standaert, D. G., Feuerstein, T. J., Penney, J. B., Young, A. B., & Landwehrmeyer, G. B. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000417)419:4<407::aid-cne1>3.0.co;2-i · Cited by 105
New therapies for the treatment of Parkinson's disease: Adenosine A2A receptor antagonists
Pinna, A., Wardas, J., Simola, N., & Morelli, M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.029 · Cited by 105
Developmental regulation and neuroprotective effects of striatal tonic GABAA currents
Santhakumar, V., Jones, R. T., & Mody, I. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.048 · Cited by 90
Gerfen, C. R. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.1002960 · Cited by 104
Self-citationThe role of intra-thalamic and thalamocortical circuits in action selection
Humphries, M. D., & GURNEY, K. N. (2002) · Network Computation in Neural Systems · doi:10.1080/net.13.1.131.156 · Cited by 104
Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses
Tecuapetla, F., Carrillo‐Reid, L., Bargas, J., & Galarraga, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703813104 · Cited by 104
The prefrontal–limbic network in depression: Modulation by hypothalamus, basal ganglia and midbrain
Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.006 · Cited by 104
Neural mechanisms of the nucleus accumbens circuit in reward and aversive learning
Hikida, T., Morita, M., & Macpherson, T. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.01.004 · Cited by 104
The subthalamic nucleus: A possible target for stereotaxic surgery in parkinson's disease
Guridi, J., Luquín, M. R., Herrero, M. T., & Obeso, J. A. (1993) · Movement Disorders · doi:10.1002/mds.870080402 · Cited by 104
Pharmacosynthetics: Reimagining the pharmacogenetic approach
Farrell, M. S., & Roth, B. L. (2013) · Brain Research · doi:10.1016/j.brainres.2012.09.043 · Cited by 103
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.